The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG‐1 metastasis markers and leads to the identification of DJ‐1 as a potential serum biomarker
暂无分享,去创建一个
R. Dwek | M. Pardo | A. Piñeiro | Ángel García | N. Zitzmann | B. Thomas | A. Akoulitchev | Raymond A. Dwek
[1] R. Dwek,et al. Proteome analysis of a human uveal melanoma primary cell culture by 2‐DE and MS , 2005, Proteomics.
[2] M. Karas,et al. Use of two‐dimensional gel electrophoresis in predictive toxicology: Identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis , 2005, Proteomics.
[3] Arun D. Singh,et al. Metastatic uveal melanoma. , 2005, Ophthalmology clinics of North America.
[4] N. Iizuka,et al. Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines , 2005, Proteomics.
[5] T. Mak,et al. DJ-1, a novel regulator of the tumor suppressor PTEN. , 2005, Cancer cell.
[6] M. T. de la Fuente,et al. Abnormal cell cycle regulation in primary human uveal melanoma cultures , 2004, Journal of cellular biochemistry.
[7] B. Davies,et al. High‐mobility group protein 1(Y): Metastasis‐associated or metastasis‐inducing? , 2004, Journal of surgical oncology.
[8] Virginia Espina,et al. Genomic and proteomic technologies for individualisation and improvement of cancer treatment. , 2004, European journal of cancer.
[9] Justis P. Ehlers,et al. Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death , 2004, Cancer Research.
[10] Tadashi Kondo,et al. Proteomic signature of human cancer cells , 2004, Proteomics.
[11] Y. Hod. Differential control of apoptosis by DJ‐1 in prostate benign and cancer cells , 2004, Journal of cellular biochemistry.
[12] Mark A. Wilson,et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Marshall,et al. How in vitro techniques have increased our understanding of uveal melanoma cellular biology. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[14] M. Burnier,et al. New prognostic factors in uveal melanomas: potential molecular targets for therapy. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[15] C. Baudouin,et al. Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line. , 2004, Experimental eye research.
[16] J. Rodrigo,et al. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. , 2004, The American journal of pathology.
[17] Li Mao,et al. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry , 2004, Clinical & Experimental Metastasis.
[18] D. Theodorescu,et al. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines , 2004, Clinical & Experimental Metastasis.
[19] P. Meltzer,et al. Molecular determinants of human uveal melanoma invasion and metastasis , 2004, Clinical & Experimental Metastasis.
[20] Y. Hod,et al. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. , 2003, Cancer research.
[21] B. Oostra,et al. DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism , 2003, Neurological Sciences.
[22] K. Jöckel,et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. , 2003, Cancer research.
[23] Arun D. Singh,et al. Survival rates with uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.
[24] T. Niki,et al. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. , 2003, Molecular cancer research : MCR.
[25] R. E. Kalina,et al. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. , 2002, Archives of ophthalmology.
[26] Suyun Huang,et al. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. , 2002, Cancer research.
[27] D. Lev,et al. Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma , 2002, Cancer biology & therapy.
[28] Kun Wang,et al. Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. , 2002, The Journal of toxicological sciences.
[29] T. Niki,et al. DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice. , 2002, Biological & pharmaceutical bulletin.
[30] David E. Misek,et al. Discordant Protein and mRNA Expression in Lung Adenocarcinomas * , 2002, Molecular & Cellular Proteomics.
[31] R. Dwek,et al. Towards complete analysis of the platelet proteome , 2002, Proteomics.
[32] Ahmedin Jemal,et al. Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.
[33] M. Amin,et al. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. , 2001, Gene.
[34] David E. Misek,et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] S Hanash,et al. Proteomics in early detection of cancer. , 2001, Clinical chemistry.
[36] C. Korch,et al. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. , 2001, Cancer research.
[37] R. Reeves,et al. Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells , 2001, Molecular and Cellular Biology.
[38] T. Kivelä,et al. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. , 2000, Ophthalmology.
[39] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[40] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[41] A. Heiligenhaus,et al. Expression of the Cell Adhesion Molecules ICAM-1, VCAM-1 and NCAM in Uveal Melanoma: A Clinicopathological Study , 2000, Oncology.
[42] I. Shih. The role of CD146 (Mel‐CAM) in biology and pathology , 1999, The Journal of pathology.
[43] M. Hendrix,et al. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[44] M. Saornil,et al. Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). , 1997, Current eye research.
[45] T. Taira,et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. , 1997, Biochemical and biophysical research communications.
[46] D. Hochstrasser,et al. Improved and simplified in‐gel sample application using reswelling of dry immobilized pH gradients , 1997, Electrophoresis.
[47] A. Podtelejnikov,et al. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] A. Hanby,et al. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. , 1996, Cancer research.
[49] J. Sampol,et al. Identification of the S-Endo 1 endothelial-associated antigen. , 1996, Biochemical and biophysical research communications.
[50] K. Hayasaka,et al. Suppression of calphobindin I (CPB I) production in carcinoma of uterine cervix and endometrium. , 1995, Gynecologic oncology.
[51] L. Romer,et al. EndoCAM: a novel endothelial cell-cell adhesion molecule , 1990, The Journal of cell biology.
[52] J. Lehmann,et al. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Balmain,et al. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. , 1989, Experimental cell research.
[54] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[55] L. Loew,et al. Charge-shift probes of membrane potential. Synthesis , 1984 .